Pdf Summary
Keywords
gynecologic oncology
PARP inhibitor rucaparib
recurrent ovarian cancer
RAD51C
RAD51D mutations
BRCA1 promoter methylation
epithelial ovarian cancer
genetic alterations
dose-dense regimen
paclitaxel
Contact education@igcs.org for assistance.
Powered By